NASDAQ:CNSP

CNS Pharmaceuticals Earning Date

USA |NASDAQ |USD

CNSP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 12, 2021 (est) Sep 30, 2021 - $-0.15 $-0.12
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 12, 2021 (est) Sep 30, 2021 - $0.00 $0.00

Cns Pharmaceuticals's next estimated earnings date (based on same quarter last year's date) is Nov 12, 2021 for the fiscal quarter ending Sep 30, 2021.

CNSP Earnings Date & History Chart

CNSP Earnings & Revenue Forecast

CNSP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.20 $-0.31 $-0.11
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.66 $-0.84 $-0.51
Dec 2022 4 $-0.74 $-1.16 $-0.51

CNSP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.20 $-0.24 $-0.24
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.66 $-0.73 $-0.73
Dec 2022 0 / 0 $-0.74 $-0.81 $-0.81

CNSP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Dec 2022 4 $0.00 $0.00 $0.00

CNSP Earnings Date & Revenue History

CNSP Earnings History

|
Show More
Show More

CNSP Revenue History

|
Show More
Show More

Cns Pharmaceuticals Next Earnings Date & Report

CNSP Aug 2021 (FQ) Earnings Date & Report Preview

CNSP's next estimated earnings date (based on same quarter last year's report date) is Nov 12, 2021 for the fiscal quarter ending Sep 30, 2021.

Cns Pharmaceuticals Previous Earnings Dates & Reports

CNSP Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Cns Pharmaceuticals's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.

CNSP's earnings per share (EPS) was $-0.15, missing the consensus analysts forecast of $-0.13 by -15.38%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 0.00%, and higher than the same period a year before (Jun 2020) by 0.00%.

Revenues were $0.00.

The company reported a net income of $-3.81M.

Free cash flow for the quarter was $-5.00M , compared to $-3.31M last quarter and $-2.75M a year before.

CNSP ended the quarter with $177.58K in total debt, a decrease of -42.55% compared to the previous quarter.

CNSP Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cns Pharmaceuticals's previous annual earnings date was Feb 12, 2021 for its fiscal year ended Dec 31, 2020.

CNSP's earnings per share (EPS) was $-0.57, missing the consensus analysts forecast of $-0.50 by 14.00% , and lower than the previous year's EPS (Dec 2019) by 147.83%.

Revenues were $0.00.

The company reported a net income of $-9.46M.

Cns Pharmaceuticals reported a free cash flow of $-7.34M for its fiscal year, compared to $-3.57M a year ago.

The company ended the fiscal year with $439.29K in total debt. lala